Please login to the form below
GDPR
This page shows the latest GDPR news and features for those working in and with pharma, biotech and healthcare.
Health leaders welcome EDPB’s opinion on adequacy of UK’s data protection standards
The EDPB said that there are key areas of alignment between the EU and the UK on data protection, as the UK had implemented the GDPR into national law before leaving
Latest news
-
Safety first: AI adoption in the healthcare sector
The GDPR introduced a right to explanation, which means that the logic of an automated decision can be challenged and the results tested – businesses will need to think carefully before building ... Where required by the GDPR, privacy impact
-
ABPI blames doctor payment disclosure dip on GDPR
or re-sought consent to meet GDPR requirements, which could explain the dip. ... GDPR applies to all industries and organisations across Europe and inevitably brings challenges for all as processes and procedures are checked,” commented the ABPI’s
-
Daily Brief: GDPR and NHS Opt Out Day, BioMarin's new rare disease approval and more
It's not just the GDPR's big day, plus news from Medigene and Pfizer. ... most of us have been bombarded with messages from companies and organisations rushing to meet the new GDPR regulations.
-
Daily Brief: AI to boost early NHS cancer diagnosis, AZ shareholder revolt, Juluca approval
new tighter European data privacy rules, the GDPR, come into force.
Safety first: AI adoption in the healthcare sector
ABPI blames doctor payment disclosure dip on GDPR
Daily Brief: GDPR and NHS Opt Out Day, BioMarin's new rare disease approval and more
Daily Brief: AI to boost early NHS cancer diagnosis, AZ shareholder revolt, Juluca approval
More from news
Approximately 2 fully matching, plus 3 partially matching documents found.
Latest Intelligence
-
What Hemingway got right about patient communications
But when physicians asked if they could use these apps to manage their patients remotely, we sensed a potentially insurmountable GDPR and pharmacovigilance challenge.
-
Exploiting the value of data in pharma
In order to facilitate access to personal data there are ethical and regulatory obstacles such as GDPR compliance or operating to GxP guidelines to address, but the importance of public health
-
Mastering data protection in the pharma industry
The enhanced rights for individuals under the GDPR may also have implications for medical research. ... GDPR consent and in such case an alternative legal basis may be required.
-
Pharmaceutical social media after Cambridge Analytica
In fact, in 2018 Facebook was fined £500, 000 – the maximum allowable at the time under the law, prior to the introduction of GDPR – by the ICO, which stated that “companies
-
01000010 01101001 01101110 01100001 01110010 01111001
As controllers and processors of data (yes, I am using a GDPR term) we have an opportunity with modern technology to address our KPIs with the same rigor, and properly quantify
What Hemingway got right about patient communications
Exploiting the value of data in pharma
Mastering data protection in the pharma industry
Pharmaceutical social media after Cambridge Analytica
01000010 01101001 01101110 01100001 01110010 01111001
More from intelligence
Approximately 1 fully matching, plus 10 partially matching documents found.
Latest from PMHub
-
PRESS RELEASE: IMPETUS DIGITAL LAUNCHES INSITE EVENT™
InSite Event is a GDPR- and HIPAA-compliant, “one-stop-shop,” completely customizable virtual event solution.
-
Press release: InSite Event™ named one of the most innovative services of 2020
InSite Event is a GDPR- and HIPAA-compliant, “all-in-one,” completely customizable virtual event solution, ideal for medical congresses, conferences, education events, and corporate meetings.
-
Impetus Digital
The HIPAA- and GDPR-compliant Impetus InSite Platform. allows for sustained healthcare stakeholder communication, collaboration, education, and insight synthesis longitudinally.
-
Are you capitalising on your pharma exhibition presence?
However, in response to the rapid growth of technology, the GDPR has significantly modified the way we can collect, store and use personal data.
-
How to add some magic to your pharma exhibition stand design
iPads. Augmented Reality/Virtual Reality. Touch screen data capture (GDPR compliant). Holograms.
Impetus Digital
How to add some magic to your pharma exhibition stand design
More from PMHub
Approximately 3 fully matching, plus 19 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Project Director, Healthcare Marketing Agency patient focus Lond...
-
Highly competitive salary
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
-
Events Executive
-
Depending on Experience
- Senior Consultant, Pricing & Market Access Consultancy, circ...
-
circa £100K package
- Digital Project Director, Healthcare Marketing Agency patient fo...
-
Highly competitive salary
-
Digital account director
-
Competitive
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Understanding the ‘real world’ starts and ends with the patient
- AZ publishes new real-world safety data for COVID-19 vaccine Vaxzevria
- Mixing AZ and Pfizer COVID-19 vaccines increases antibody levels
- Michael J. Fox Foundation and IBM reveal new AI model for Parkinson’s disease
- Sanofi raises profit forecast following positive Q2 results
- Biogen/Eisai push for second approval in Alzheimer’s disease
- Reducing primary care antibiotic use may not be enough to counter antimicrobial resistance
- SoftBank buys $5bn stake in Roche
- Live Webinar: Making Wearable Technology Scalable and Adoptable
- Live Webinar: Transforming the Future of Health & Aging from a Global Health & Social Impact Approach
- Investors respond positively to “strong” Eli Lilly results
- Amanda Pritchard becomes NHS England’s first female chief executive
- Biogen/Eisai push for second approval in Alzheimer’s disease
- Mixing AZ and Pfizer COVID-19 vaccines increases antibody levels
- Understanding the ‘real world’ starts and ends with the patient
- BioNTech plans acquisition of Kite’s TCR cell therapy R&D platform
- Amgen pays $900m upfront to acquire Teneobio’s antibody assets, R&D technologies
PMHub
Origins Insights
Our goal is to identify and embed transformational patient insights as a fundamental part of the drug development process. As...
Latest intelligence
- Ask the writers: Transitioning from academia to medical writing
- Porterhouse Medical's talented writers talk about their transition from academia and give advice to those people considering a career in medical writing...
- Strategic launch planning: familiar framework, new mindset
- By James Aird...
- Guide
- How to embrace behavioural science principles in healthcare MR...
